Health Insight: Mar 14, 2026
The latest discourse on health optimisation and longevity points to a significant trend in 2026: the increasing prominence and scrutiny of GLP-1 receptor agonists for weight management, particularly among non-diabetic individuals. While these medications have revolutionised type 2 diabetes management, their off-label use and efficacy for broader weight loss are now at the forefront of …